Moneycontrol

Budget 2021

Associate Partners:

  • SMC
  • Samsung
  • Volvo

Moneycontrol

Budget 2021

Associate Partners:

  • SMCSamsungVolvo
Webinar :Join an expert panel for a webinar on Smart investments for a secure retirement January 28, 2021. Register now!
you are here: HomeNewsBusiness

Serum Institute says India trials of COVID-19 vaccine ongoing

AstraZeneca said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a study participant.

September 09, 2020 / 09:47 PM IST

Serum Institute of India said on Wednesday that trials of AstraZeneca Plc's COVID-19 vaccine candidate in the country is ongoing and has not faced any issues.

AstraZeneca said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a study participant.

"We can't comment much on the U.K. trials," Serum Institute said in a statement, adding "as far as Indian trials are concerned, it is continuing and we have faced no issues at all."
Reuters
Sections